Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

Delayed Quote. Delayed  - 06/28 04:24:58 pm
19040 ILa   -0.16%
09:39p Teva, Allergan sell product lines to Australian co
05:04p TEVA PHARMACEUT : and Antares Pharma Announce Launch of Generic Imit..
02:06p TEVA PHARMACEUT : Announces FDA Acceptance of New Drug Applications ..
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Illumina: Teva Pharmaceutical Exclusive Distributor of Verifi Test in Israel

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/01/2013 | 01:27pm CEST
   By Melodie Warner 
 

Illumina Inc. (>> Illumina, Inc.) said Teva Pharmaceutical Industries Ltd. (>> Teva Pharmaceutical Industries Ltd (ADR)) will be the exclusive distributor of the verifi prenatal test in Israel under a five-year agreement.

Financial terms weren't disclosed.

Illumina paid $350 million in February to buy Verinata Health Inc., which gave it access to Verinata's verifi prenatal test, the broadest non-invasive prenatal test currently available for high-risk pregnancies.

The company said the MOR Institute for Medical Data Ltd., through its relationship with Teva, will provide the verifi test to customers of Clalit Health Services who are at high risk of having a fetus with a chromosomal abnormality.

The MOR Institute will also establish a 9,000-patient clinical outcomes registry to collect performance data and will share the data with Verinata.

Illumina said the patient registry developed through this collaboration will be the largest and most extensive of its kind.

Illumina shares closed Friday at $74.84 and were inactive premarket. The stock is up 35% this year.

Write to Melodie Warner at melodie.warner@dowjones.com

Stocks mentioned in the article : Illumina, Inc., Teva Pharmaceutical Industries Ltd (ADR)
share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on TEVA PHARMACEUTICAL INDUST
09:39p Teva, Allergan sell product lines to Australian co
05:04p TEVA PHARMACEUTICAL : and Antares Pharma Announce Launch of Generic Imitrex in t..
02:06p TEVA PHARMACEUTICAL : Announces FDA Acceptance of New Drug Applications for Flut..
06/27DJMayne Pharma Buys US Drugs from Teva, Allergan for $652 Million
06/27 TEVA PHARMACEUTICAL : and Antares Pharma Announce Launch of Generic Imitrex® in ..
06/24 TEVA PHARMACEUTICAL : Receives CHMP Positive Opinion for CINQAERO® (reslizumab)
06/23 TEVA PHARMACEUTICAL : Announces Voluntary Suspension of Marketing for ZECUITY® i..
06/23 TEVA PHARMACEUTICAL : Settles Patent Litigation with AstraZeneca Allowing to Com..
06/21 CADILA HEALTHCARE : Zydus Cadila to acquire two ANDAs from Teva Pharmaceutical I..
06/21DJTeva and Allergan Sell Generic Drugs to Impax In Latest Divestiture
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials